July 2020
Volume 61, Issue 9
Free
ARVO Imaging in the Eye Conference Abstract  |   July 2020
Bruch’s membrane opening detection in healthy and glaucoma eyes with and without high myopia in an American and Korean population
Author Affiliations & Notes
  • Jasmin Rezapour
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
    Ophthalmology, University Medical Center Mainz, Mainz, Germany
  • James Proudfoot
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Christopher Bowd
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Mark Christopher
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Akram Belghith
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Suzanne M. Vega
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Keri Dirkes
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Min Hee Suh
    Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Korea (the Republic of)
  • Robert N Weinreb
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Linda Zangwill
    Hamilton Glaucoma Center, Shiley Eye Institute, San Diego, California, United States
  • Footnotes
    Commercial Relationships   Jasmin Rezapour, None; James Proudfoot, None; Christopher Bowd, None; Mark Christopher, None; Akram Belghith, None; Suzanne Vega, None; Keri Dirkes, None; Min Suh, None; Robert Weinreb, Aerie Pharmaceuticals (C), Allergan (C), Bausch&Lomb (F), Bausch&Lomb (C), Carl Zeiss Meditec (F), Centervue (F), Eyenovia (C), Heidelberg Engineering GmbH (F), Konan Medical (F), Meditec-Zeiss (P), Optovue (F), Toromedes (P); Linda Zangwill, Carl Zeiss Meditec Inc. (F), Heidelbeg Engineering (R), Heidelberg Engineering GmbH (F), Meditec- Zeiss (P), National Eye Institute (F), Optovue Inc. (F), Topcon Medical Systems Inc. (F)
  • Footnotes
    Support  Jasmin Rezapour: German Research Foundation research fellowship grant recipient (RE 4155/1-1) and German Ophthalmological Society grant, DIGS: EY11008, EY19869, EY14267, EY027510, EY026574, EY029058, P30EY022589, UCSD School of Medicine Summer Research Fellowship, and participant retention incentive grants in the form of glaucoma medication at no cost from Novartis/Alcon Laboratories Inc, Allergan, Akorn, and Pfizer Inc. Unrestricted grant from Research to Prevent Blindness, New York, New York
Investigative Ophthalmology & Visual Science July 2020, Vol.61, PB00117. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jasmin Rezapour, James Proudfoot, Christopher Bowd, Mark Christopher, Akram Belghith, Suzanne M. Vega, Keri Dirkes, Min Hee Suh, Robert N Weinreb, Linda Zangwill; Bruch’s membrane opening detection in healthy and glaucoma eyes with and without high myopia in an American and Korean population. Invest. Ophthalmol. Vis. Sci. 2020;61(9):PB00117.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess the proportions of automatic, manually corrected and indiscernible Bruch’s membrane openings (BMO) in eyes with and without high myopia and to investigate factors associated with indiscernible BMOs.

Methods : Glaucoma patients and healthy subjects from the Diagnostic Innovations in Glaucoma Study (DIGS) and Korean clinic population were included. Healthy and glaucoma eyes were classified into 2 groups by axial length (AL); no high myopia (AL <26mm) and high myopia (AL ≥26mm). Spectralis optic nerve head (ONH) scans containing 24 radial B-scans were utilized to automatically detect the BMO. All radial scans were reviewed by a trained operator and BMO placement manually corrected as needed. BMO was recorded as discernible or indiscernible and whether a seconder operator was needed to assist. Linear and logistic generalized estimating equations (GEE) were used to compare eye characteristics between groups.

Results : 143 healthy eyes (76 subjects) and 344 glaucoma eyes (224) were included. 28 (19.6%) and 42 eyes (12.2%) in the healthy and glaucoma group were high myopes. In healthy eyes with and without high myopia, 10.7% and 1.7% had indiscernible BMOs, 28.6% and 11.3% were corrected, and 60.7% and 87.0% were automatically segmented (respectively, p=0.03). In glaucoma eyes with and without high myopia, 7.1% and 3.0% had indiscernible BMOs, 45.2% and 37.4% were corrected, and 47.6% and 59.6% were automatically segmented (respectively, p=0.23). In eyes with high myopia, a second operator was required in 17.9% of the healthy and 11.9% of the glaucoma eyes. The proportion of high myopes was significantly higher among eyes with indiscernible BMOs (6/17, 35.3%) compared to eyes with corrected (27/126, 17.6%) and automatic BMOs (37/280, 11.7%) (p=0.05). BMO tilt was significantly higher in corrected and indiscernible BMOs (p=0.02) and OCT scans were more often decentered in eyes with indiscernible BMOs (p<0.01). Proportions of corrected and indiscernible BMOs were also significantly higher in healthy and glaucoma Korean eyes with high myopia compared to eyes without high myopia.

Conclusions : High axial myopia was associated with indiscernible BMOs, which may affect the diagnostic value of BMO-MRW for glaucoma assessment in highly myopic eyes.

This is a 2020 Imaging in the Eye Conference abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×